| Year |
Citation |
Score |
| 2018 |
Abbott JR, Hodges TR, Daniels RN, Patel PA, Kennedy JP, Howes JE, Akan DT, Burns MC, Sai J, Sobolik T, Beesetty Y, Lee T, Rossanese OW, Phan J, Waterson AG, et al. Discovery of Aminopiperidine Indoles That Activate the Guanine Nucleotide Exchange Factor SOS1 and Modulate RAS Signaling. Journal of Medicinal Chemistry. PMID 29856609 DOI: 10.2210/Pdb6Bvl/Pdb |
0.312 |
|
| 2014 |
Sheffler DJ, Nedelovych MT, Williams R, Turner SC, Duerk BB, Robbins MR, Jadhav SB, Niswender CM, Jones CK, Conn PJ, Daniels RN, Lindsley CW. Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: development of a [3.3.0]-based series and other piperidine bioisosteres. Bioorganic & Medicinal Chemistry Letters. 24: 1062-6. PMID 24462664 DOI: 10.1016/J.Bmcl.2014.01.011 |
0.431 |
|
| 2013 |
Friberg A, Vigil D, Zhao B, Daniels RN, Burke JP, Garcia-Barrantes PM, Camper D, Chauder BA, Lee T, Olejniczak ET, Fesik SW. Discovery of potent myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods and structure-based design. Journal of Medicinal Chemistry. 56: 15-30. PMID 23244564 DOI: 10.1021/Jm301448P |
0.601 |
|
| 2010 |
Miller NR, Daniels RN, Lee D, Conn PJ, Lindsley CW. Synthesis and SAR of N-(4-(4-alklylpiperazin-1-yl)phenyl)benzamides as muscarinic acetylcholine receptor subtype 1 (M1) anatgonists. Bioorganic & Medicinal Chemistry Letters. 20: 2174-7. PMID 20202841 DOI: 10.1016/J.Bmcl.2010.02.041 |
0.395 |
|
| 2010 |
Hao J, Ho JN, Lewis JA, Karim KA, Daniels RN, Gentry PR, Hopkins CR, Lindsley CW, Hong CC. In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors. Acs Chemical Biology. 5: 245-53. PMID 20020776 DOI: 10.1021/Cb9002865 |
0.339 |
|
| 2009 |
Daniels RN, Melancon BJ, Wang EA, Crews BC, Marnett LJ, Sulikowski GA, Lindsley CW. Progress toward the total synthesis of lucentamycin A: total synthesis and biological evaluation of 8-epi-lucentamycin A. The Journal of Organic Chemistry. 74: 8852-5. PMID 19908916 DOI: 10.1021/Jo902115S |
0.491 |
|
| 2008 |
Miller NR, Daniels RN, Bridges TM, Brady AE, Conn PJ, Lindsley CW. Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen. Bioorganic & Medicinal Chemistry Letters. 18: 5443-7. PMID 18829311 DOI: 10.1016/J.Bmcl.2008.09.032 |
0.434 |
|
| 2008 |
Bridges TM, Brady AE, Kennedy JP, Daniels RN, Miller NR, Kim K, Breininger ML, Gentry PR, Brogan JT, Jones CK, Conn PJ, Lindsley CW. Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties. Bioorganic & Medicinal Chemistry Letters. 18: 5439-42. PMID 18805692 DOI: 10.1016/J.Bmcl.2008.09.023 |
0.508 |
|
| 2008 |
Lewis JA, Daniels RN, Lindsley CW. Total synthesis of Ciliatamides A-C: stereochemical revision and the natural product-guided synthesis of unnatural analogs. Organic Letters. 10: 4545-8. PMID 18788742 DOI: 10.1021/Ol801842V |
0.398 |
|
| 2008 |
Daniels RN, Fadeyi OO, Lindsley CW. A new catalytic Cu(II)/sparteine oxidant system for beta,beta-phenolic couplings of styrenyl phenols: synthesis of carpanone and unnatural analogs. Organic Letters. 10: 4097-100. PMID 18729467 DOI: 10.1021/Ol801643T |
0.576 |
|
| 2008 |
Kennedy JP, Williams L, Bridges TM, Daniels RN, Weaver D, Lindsley CW. Application of combinatorial chemistry science on modern drug discovery. Journal of Combinatorial Chemistry. 10: 345-54. PMID 18220367 DOI: 10.1021/Cc700187T |
0.419 |
|
| 2008 |
Daniels RN, Kim K, Lebois EP, Muchalski H, Hughes M, Lindsley CW. Microwave-assisted protocols for the expedited synthesis of pyrazolo[1,5-a] and [3,4-d]pyrimidines Tetrahedron Letters. 49: 305-310. DOI: 10.1016/J.Tetlet.2007.11.054 |
0.651 |
|
| 2008 |
Daniels RN, Kim K, Lebois EP, Muchalski H, Hughes M, Lindsley CW. ChemInform Abstract: Microwave-Assisted Protocols for the Expedited Synthesis of Pyrazolo[1,5-a] and [3,4-d]Pyrimidines. Cheminform. 39. DOI: 10.1002/chin.200816176 |
0.636 |
|
| Show low-probability matches. |